Loading clinical trials...
Loading clinical trials...
A Phase I/II Institutional Study of Abraxane in Recurrent and Refractory Lymphoma
Conditions
Interventions
Abraxane
Locations
2
United States
St. Louis University School of Medicine
St Louis, Missouri, United States
Washington University School of Medicine
St Louis, Missouri, United States
Start Date
July 1, 2012
Primary Completion Date
June 1, 2016
Completion Date
June 1, 2016
Last Updated
December 6, 2016
NCT06510361
NCT05442515
NCT07162181
NCT06528301
NCT07209059
NCT05824585
Lead Sponsor
Washington University School of Medicine
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions